(Q72362556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

phase I clinical trial

1 reference

J H Schiller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

B Storer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

R Arzoomanian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

K Tutsch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

D Alberti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

D Spriggs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

291-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

26 October 2019

cites work

1 reference

12 December 2020

High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease

1 reference

12 December 2020

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease

1 reference

12 December 2020

The cardiotoxicity of chemotherapeutic drugs

1 reference

12 December 2020

Phase II study of mitoxantrone in epithelial ovarian cancer

1 reference

12 December 2020

Activity of mitoxantrone in a human tumor cloning system

1 reference

12 December 2020

Hematopoietic growth factors. Biology and clinical applications

1 reference

12 December 2020

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer

1 reference

12 December 2020

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

12 December 2020

A comparison of mitoxantrone and doxorubicin in breast cancer.

1 reference

12 December 2020

Clinical safety and tolerance of mitoxantrone

1 reference

12 December 2020

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

12 December 2020

Mitoxantrone: an active, new antitumor agent with an improved therapeutic index

1 reference

12 December 2020

Mitoxantrone: potential for use in intensive therapy.

1 reference

12 December 2020

High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors

1 reference

12 December 2020

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

12 December 2020

New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignancies

1 reference

12 December 2020

Pharmacokinetics and metabolism of mitoxantrone. A review

1 reference

12 December 2020

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

1 reference

12 December 2020

Comment on mitoxantrone

1 reference

12 December 2020

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

1 reference

12 December 2020

Mitoxantrone: an overview of safety and toxicity

1 reference

12 December 2020

Mitoxantrone: a new anticancer drug with significant clinical activity

1 reference

12 December 2020

Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids

1 reference

12 December 2020

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer

1 reference

12 December 2020

Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Intensive single-agent mitoxantrone for metastatic breast cancer

1 reference

12 December 2020

In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.

1 reference

12 December 2020

Mitoxantrone (novantrone): a review of experimental and early clinical studies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00874427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8157471%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference